|
21 Companies |
|
32 Products |
|
32 Products |
|
31 Mechanisms of Action |
|
0 Trials |
|
631 News |
|
| «123456789101112» |
- |||| lacosamide / Generic mfg.
Trial completion: Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures (clinicaltrials.gov) - Aug 28, 2013
P4, N=461, Completed, Sponsor: UCB, Inc.
Active, not recruiting --> Completed
- Enrollment closed: The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS) (clinicaltrials.gov) - Aug 26, 2013
P=N/A, N=409, Active, not recruiting, Sponsor: Stanford University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: METHORIVAC - Vaccinal Pharmacoepidemiologic (clinicaltrials.gov) - Aug 26, 2013
P=N/A, N=500, Completed, Sponsor: Centre Hospitalier Universitaire Dijon
Recruiting --> Active, not recruiting Not yet recruiting --> Completed
- |||||||||| lacosamide / Generic mfg.
New P3 trial: Study to Investigate Lacosamide as Add-on Therapy in Subjects ?4 Years to <17 Years of Age With Partial Onset Seizures (clinicaltrials.gov) - Aug 11, 2013
P3, N=300, Ongoing, Sponsor: UCB BIOSCIENCES, Inc.
- | New trial: Auricular Acupuncture For The Treatment Of Non-Epileptic Seizures (clinicaltrials.gov) - Aug 7, 2013
P=N/A, N=80, Recruiting, Sponsor: Denver Health and Hospital Authority
- || levetiracetam / Generic mfg.
Trial completion: A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures (clinicaltrials.gov) - Jul 29, 2013
P3, N=13, Completed, Sponsor: UCB, Inc.
Not yet recruiting --> Completed Recruiting --> Completed
- Clinical: Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy (clinicaltrials.gov) - Jul 25, 2013
P=N/A, N=30, Recruiting, Sponsor: ElectroCore LLC
- | clonazepam / Generic mfg., lorazepam / Generic mfg., fosphenytoin / Generic mfg.
Enrollment open: LORACLOFT: Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus (clinicaltrials.gov) - Jul 25, 2013
P3, N=522, Recruiting, Sponsor: Assistance Publique - H
Recruiting --> Completed Not yet recruiting --> Recruiting
- risedronate / Generic mfg.
Trial completion: ADOPT: Antiepileptic Drugs and Osteoporotic Prevention Trial (clinicaltrials.gov) - Jul 22, 2013
P4, N=80, Completed, Sponsor: Boston VA Research Institute, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||| levetiracetam / Generic mfg.
Enrollment closed: UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra (clinicaltrials.gov) - Jul 18, 2013
P4, N=516, Active, not recruiting, Sponsor: UCB, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- levetiracetam / Generic mfg.
Enrollment change: Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria (clinicaltrials.gov) - Jul 15, 2013
P1/2, N=7, Completed, Sponsor: Michigan State University
Recruiting --> Active, not recruiting N=30 --> 7
- Enrollment closed: The Relevance of Performing Lumbar Puncture in Infants Aged 3 to 12 Months With First Episode of Febrile Convulsion (clinicaltrials.gov) - Jul 15, 2013
P=N/A, N=300, Active, not recruiting, Sponsor: HaEmek Medical Center, Israel
N=30 --> 7 Recruiting --> Active, not recruiting
- levetiracetam / Generic mfg.
Trial completion: Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria (clinicaltrials.gov) - Jul 15, 2013
P1/2, N=7, Completed, Sponsor: Michigan State University
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||| lacosamide / Generic mfg.
Trial completion: VITOBA: Vimpat (clinicaltrials.gov) - Jul 14, 2013
P=N/A, N=576, Completed, Sponsor: UCB Pharma GmbH
Recruiting --> Completed Active, not recruiting --> Completed
- Trial initiation date: Nervous System Infections Among Patients With Febrile Seizure (clinicaltrials.gov) - Jul 4, 2013
P=N/A, N=1000, Recruiting, Sponsor: H
Active, not recruiting --> Completed Initiation date: Oct 2012 --> Jun 2013
- Enrollment open: Nervous System Infections Among Patients With Febrile Seizure (clinicaltrials.gov) - Jul 4, 2013
P=N/A, N=1000, Recruiting, Sponsor: H
Initiation date: Oct 2012 --> Jun 2013 Not yet recruiting --> Recruiting
- | Enrollment closed, Monotherapy: Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and Adolescents (clinicaltrials.gov) - Jul 2, 2013
P3, N=20, Active, not recruiting, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- HEOR: Enhancing Physical Activity Levels in Children With Epilepsy (clinicaltrials.gov) - Jun 27, 2013
P=N/A, N=100, Recruiting, Sponsor: Children's Hospital of Eastern Ontario
- Enrollment change: Characteristics Predictive of Pessary Success (clinicaltrials.gov) - Jun 26, 2013
P=N/A, N=158, Completed, Sponsor: University of California, Irvine
Recruiting --> Active, not recruiting N=200 --> 158
- || Enrollment closed: Acid Suppressing Drug Seizure Epidemiology Study (clinicaltrials.gov) - Jun 26, 2013
P0, N=534, Active, not recruiting, Sponsor: AstraZeneca
N=200 --> 158 Recruiting --> Active, not recruiting
- Trial completion: Characteristics Predictive of Pessary Success (clinicaltrials.gov) - Jun 26, 2013
P=N/A, N=158, Completed, Sponsor: University of California, Irvine
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment open, HEOR, Surgery: Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery (clinicaltrials.gov) - Jun 19, 2013
P=N/A, N=170, Recruiting, Sponsor: Radiation Therapy Oncology Group
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- bumetanide / Generic mfg.
Trial completion: NEMO1:NEonatal Seizure Using Medication Off-patent (clinicaltrials.gov) - Jun 18, 2013
P1/2, N=49, Completed, Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment open: Why Are Patients With Absence Seizures Absent? A Brain Imaging Study (clinicaltrials.gov) - Jun 9, 2013
P=N/A, N=180, Recruiting, Sponsor: Yale University
Recruiting --> Completed Active, not recruiting --> Recruiting
- ||||| Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL
Enrollment closed, Monotherapy: Eslicarbazepine Acetate Monotherapy Long Term Study (clinicaltrials.gov) - Jun 9, 2013
P3, N=348, Active, not recruiting, Sponsor: Sunovion
Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting
- || clonazepam / Generic mfg., lorazepam / Generic mfg., fosphenytoin / Generic mfg.
New P3 trial: LORACLOFT: Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus (clinicaltrials.gov) - Jun 3, 2013
P3, N=522, Recruiting, Sponsor: Assistance Publique - H
- ||| Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL
Enrollment closed: Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients (clinicaltrials.gov) - Jun 2, 2013
P4, N=100, Active, not recruiting, Sponsor: Bial - Portela C S.A.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial termination: Prevention of Photoparoxysmal Abnormalities by Mozart K448 (clinicaltrials.gov) - Jun 1, 2013
P=N/A, N=10, Terminated, Sponsor: Medical University of South Carolina
Recruiting --> Active, not recruiting Recruiting --> Terminated; terminated
- Enrollment change: Prevention of Photoparoxysmal Abnormalities by Mozart K448 (clinicaltrials.gov) - Jun 1, 2013
P=N/A, N=10, Terminated, Sponsor: Medical University of South Carolina
Recruiting --> Terminated; terminated N=30 --> 10
- phenytoin / Generic mfg., levetiracetam / Generic mfg., fosphenytoin / Generic mfg.
Clinical: Antiepileptic Drugs and Vascular Risk Markers (clinicaltrials.gov) - May 20, 2013
P=N/A, N=40, Terminated, Sponsor: Thomas Jefferson University
N=30 --> 10 Recruiting --> Terminated; study no longer consistent with current clinical practice
- | phenytoin / Generic mfg., levetiracetam / Generic mfg., fosphenytoin / Generic mfg.
Trial termination: Antiepileptic Drugs and Vascular Risk Markers (clinicaltrials.gov) - May 20, 2013
P=N/A, N=40, Terminated, Sponsor: Thomas Jefferson University
Recruiting --> Terminated; study no longer consistent with current clinical practice N=200 --> 40 | Recruiting --> Terminated; study no longer consistent with current clinical practice
- pregabalin / Generic mfg., levetiracetam / Generic mfg.
Trial completion, Monotherapy: Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors (clinicaltrials.gov) - May 20, 2013
P2, N=52, Completed, Sponsor: Dr Andrea Rossetti
N=200 --> 40 | Recruiting --> Terminated; study no longer consistent with current clinical practice Active, not recruiting --> Completed
- Clinical: Exercise Education for Adults With Seizure Disorders (clinicaltrials.gov) - May 15, 2013
P0, N=50, Recruiting, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
- Trial completion: External Trigeminal Nerve Stimulation for Epilepsy (clinicaltrials.gov) - May 5, 2013
P2, N=50, Completed, Sponsor: Olive View-UCLA Education & Research Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || New P3 trial: New Magnesium Sulphate Protocol for Pre-eclampsia (clinicaltrials.gov) - May 1, 2013
P3, N=240, Completed, Sponsor: Cairo University
- carbamazepine / Generic mfg.
Trial completion, Adverse drug reaction: Pathogenesis of Adverse Drug Reactions (clinicaltrials.gov) - Apr 28, 2013
P=N/A, N=98, Completed, Sponsor: Children's Mercy Hospital Kansas City
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| topiramate XR / Generic mfg.
Trial completion: Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures (clinicaltrials.gov) - Apr 25, 2013
P3, N=249, Completed, Sponsor: Upsher-Smith Laboratories
Active, not recruiting --> Completed Active, not recruiting --> Completed
- levetiracetam / Generic mfg.
Trial termination: Efficacy of Keppra for Neonatal Seizures (clinicaltrials.gov) - Apr 16, 2013
P=N/A, N=2, Terminated, Sponsor: Stephanie Merhar, MD
Active, not recruiting --> Completed Active, not recruiting --> Terminated; difficulty with recruitment
- levetiracetam / Generic mfg.
Enrollment change: Efficacy of Keppra for Neonatal Seizures (clinicaltrials.gov) - Apr 16, 2013
P=N/A, N=2, Terminated, Sponsor: Stephanie Merhar, MD
Active, not recruiting --> Terminated; difficulty with recruitment N=25 --> 2
- Trial completion: Internet-based Pre-fitting Counseling of Persons With Hearing Impairment (clinicaltrials.gov) - Apr 15, 2013
P=N/A, N=80, Completed, Sponsor: Thomas Lunner
N=25 --> 2 Not yet recruiting --> Completed
- |||||| Enrollment open: Modified Atkins Diet Plus KetoCal for Adult Epilepsy (clinicaltrials.gov) - Apr 14, 2013
P2/3, N=80, Recruiting, Sponsor: Johns Hopkins University
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment open: Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design (clinicaltrials.gov) - Apr 12, 2013
P4, N=36, Recruiting, Sponsor: University of Cincinnati
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Plumiaz (diazepam nasal spray) / Acorda
Enrollment change: A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode (clinicaltrials.gov) - Apr 1, 2013
P2, N=31, Completed, Sponsor: Acorda Therapeutics
Not yet recruiting --> Recruiting N=40 --> 31
- | Plumiaz (diazepam nasal spray) / Acorda
Trial completion: A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode (clinicaltrials.gov) - Apr 1, 2013
P2, N=31, Completed, Sponsor: Acorda Therapeutics
N=40 --> 31 Enrolling by invitation --> Completed
- Trial withdrawal: GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures (clinicaltrials.gov) - Mar 31, 2013
P2, N=0, Withdrawn, Sponsor: GlaxoSmithKline
Enrolling by invitation --> Completed Terminated --> Withdrawn
- Enrollment change: GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures (clinicaltrials.gov) - Mar 31, 2013
P2, N=0, Withdrawn, Sponsor: GlaxoSmithKline
Terminated --> Withdrawn N=50 --> 0
- |||||||||| New P2/3 trial: Modified Atkins Diet Plus KetoCal for Adult Epilepsy (clinicaltrials.gov) - Mar 31, 2013
P2/3, N=80, Recruiting, Sponsor: Johns Hopkins University
- ||||| clobazam / Generic mfg.
Enrollment change: LGS: Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome (clinicaltrials.gov) - Mar 21, 2013
P3, N=267, Completed, Sponsor: Lundbeck LLC
N=50 --> 0 N=217 --> 267
- ||||||| Aptiom (eslicarbazepine) / Sumitomo Pharma, BIAL
Trial completion, Monotherapy: Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic (clinicaltrials.gov) - Mar 21, 2013
P3, N=174, Completed, Sponsor: Sunovion
N=217 --> 267 Active, not recruiting --> Completed
- Trial completion: Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy (clinicaltrials.gov) - Mar 17, 2013
P=N/A, N=331, Completed, Sponsor: Emory University
Active, not recruiting --> Completed Active, not recruiting --> Completed